Page 17 of 18
PA7.1,PA22.1-5 | Diagnostic Cytology & Clinical Pathology — Case Study
CLINICAL SCENARIO
A 38-year-old woman presents with 10-day progressive jaundice, pale stools, dark urine, and right-upper-quadrant discomfort. Her primary-care physician has ordered a liver function panel, urine dipstick with microscopy, and a complete blood count. An abdominal ultrasound reveals a 2.8 cm hypoechoic mass at the head of the pancreas; a subsequent FNAC of the mass is sent to the laboratory. Your task is to interpret each panel systematically, localise the jaundice mechanistically, integrate the cytology report, and reason to a clinically defensible diagnosis.
Instructions
Work through all six sections in order. Each section builds on the last — do NOT skip ahead. Base your reasoning on the data provided; state any additional investigations you would request and why. Use systematic frameworks (prehepatic / hepatic / posthepatic; hepatocellular vs. cholestatic LFT pattern). Cite at least two competency-mapped concepts per section. Maximum word count: 1,400 words total across all sections.
Length: Total 1,400 words maximum across all six sections. Approximate section budgets are given in each guidance note. Quality of reasoning matters more than word count — do not pad.
What to Submit
Section 1 — LFT Pattern Recognition (PA22.1, PA22.2)
The following liver function results are available:
| Parameter | Patient | Reference |
|---|---|---|
| Total bilirubin | 9.8 mg/dL | <1.2 |
| Direct (conjugated) bilirubin | 8.6 mg/dL | <0.3 |
| ALT | 62 U/L | <45 |
| AST | 54 U/L | <40 |
| ALP | 420 U/L | 44–147 |
| GGT | 310 U/L | <55 |
| Albumin | 3.8 g/dL | 3.5–5.0 |
| PT/INR | 1.1 | <1.2 |
Classify the LFT pattern as hepatocellular, cholestatic, or mixed. Justify your classification using the AST/ALT to ALP ratio and the individual enzyme elevations. Comment on synthetic function.
Guidance: Focus on the enzyme ratio (transaminases vs. ALP/GGT). A ratio <1.5 (ALP/ALT dominant) favours cholestasis. Normal albumin + INR = preserved synthetic function. Expect ~150 words.
Section 2 — Bilirubin Fractions & Jaundice Localisation (PA22.2, PA22.3)
Given the bilirubin fractions (direct 8.6 / total 9.8 mg/dL, i.e. ~88% conjugated), and the urinalysis:
| Parameter | Result |
|---|---|
| Urine colour | Dark amber |
| Urine bilirubin (dipstick) | 3+ positive |
| Urine urobilinogen | Absent |
| Urine microscopy | No casts; no haemolysis products |
Using the bilirubin-metabolism pathway, localise the jaundice to prehepatic, hepatic, or posthepatic. Explain why conjugated bilirubin appears in urine, why urobilinogen is absent, and what the pale stools indicate mechanistically.
Guidance: Key logic chain: conjugated bilirubin is water-soluble → renal excretion; absent urobilinogen + pale stools = bile duct obstruction blocking intestinal bilirubin → no stercobilin/urobilinogen. Expect ~200 words.
Section 3 — Differential Diagnosis & Ranking (PA7.1, PA22.3)
Based on Sections 1 and 2, generate a ranked differential diagnosis for posthepatic (obstructive) jaundice in this patient. For each condition, state the single most discriminating feature that makes it more or less likely in this case (age, gender, mass on ultrasound, duration, constitutional symptoms). Include at least four differentials spanning benign and malignant causes.
Guidance: Expected differentials: carcinoma head of pancreas (most likely given mass + age + progressive course), choledocholithiasis, cholangiocarcinoma, ampullary carcinoma, primary sclerosing cholangitis (less likely). Students should rank by pre-test probability. Expect ~200 words.
Section 4 — FNAC Interpretation (PA7.1, PA22.4)
The cytopathology report reads:
"Smears show cellular aspirate with clusters and single malignant epithelial cells arranged in acinar/ductal patterns. Cells exhibit nuclear enlargement with irregular nuclear membranes, prominent nucleoli (1–2 per cell), coarse chromatin, and moderate pale cytoplasm. Background shows necrotic debris and inflammatory cells. Mucinous material is present intracellularly. No normal acinar tissue seen."
Morphology classification: Adenocarcinoma, consistent with pancreatic ductal origin.
(a) Identify and define five cytological features of malignancy visible in this report. (b) Explain the diagnostic utility of FNAC vs. core-needle biopsy for a pancreatic head mass. (c) State one key limitation of FNAC in this context.
Guidance: Malignant features: nuclear enlargement, irregular nuclear membrane, prominent nucleoli, coarse chromatin, necrosis. FNAC advantage = less invasive, rapid; limitation = sampling error, no architectural assessment (histology needed to grade). Expect ~220 words.
Section 5 — Integrated Diagnosis & Pathophysiology (PA22.1–22.5)
Synthesise all evidence (LFT pattern, bilirubin localisation, clinical features, FNAC) into a final integrated diagnosis. Then explain the pathophysiological mechanism by which a mass at the head of the pancreas produces obstructive jaundice — trace the sequence from ductal obstruction to conjugated hyperbilirubinaemia, pale stools, dark urine, and pruritus. Use a numbered mechanistic chain (minimum 6 steps).
Guidance: Expected chain: mass → CBD compression → bile back-pressure → failure of bile entry into duodenum → (i) no bilirubin to intestine → pale stools + absent urobilinogen; (ii) conjugated bilirubin refluxes into blood → hyperbilirubinaemia → renal excretion → dark urine; (iii) retained bile salts → pruritus. Expect ~230 words.
Section 6 — Clinical Pathology Communication & Reflection (PA22.5)
You are the pathology registrar. Write a concise structured report (4–6 bullet points, ≤120 words) summarising the key laboratory findings, the localised diagnosis, and the FNAC result for the treating surgeon's handover. Then, in 2–3 sentences, reflect: what one aspect of this case most challenged your reasoning, and what would you look for differently on a similar next case?
Guidance: Report should cover: cholestatic LFT pattern, conjugated hyperbilirubinaemia, obstructive localisation, FNAC adenocarcinoma. Reflection is personal and ungraded but required for peer-review exercise. Expect ~180 words.
Grading Rubric — G7 Case Study Rubric — Jaundice Workup (30 points)
| Criterion | Points | Full-marks descriptor |
|---|---|---|
| LFT Pattern Classification & Enzyme Interpretation (PA22.1, PA22.2) | 6 pts | Correctly classifies pattern as cholestatic using AST/ALT vs ALP/GGT ratio with precise quantitative reasoning; accurately comments on preserved synthetic function (albumin + INR); demonstrates command of each enzyme's organ-level source. |
| Bilirubin Fractions & Jaundice Localisation (PA22.2, PA22.3) | 6 pts | Correctly localises to posthepatic; provides mechanistically complete explanation: conjugated bilirubin → water-soluble → renal excretion → dark urine; obstructed bile → no intestinal bilirubin → absent urobilinogen → pale stools; all four urinalysis findings integrated. |
| Differential Diagnosis — Breadth, Ranking & Justification (PA7.1, PA22.3) | 5 pts | Four or more differentials listed spanning benign and malignant causes; pancreatic ductal adenocarcinoma ranked first with clear discriminating features; each differential justified by a single most-discriminating feature relevant to this case; pre-test probability reasoning explicit. |
| FNAC Cytological Feature Identification & Utility Analysis (PA7.1, PA22.4) | 7 pts | All five malignant cytological features correctly identified and defined (nuclear enlargement, irregular nuclear membrane, prominent nucleoli, coarse chromatin, necrotic background or mucinous material); FNAC vs. core-needle biopsy comparison is accurate and contextually justified; one meaningful limitation stated with mechanistic basis (e.g. sampling error, lack of architectural context). |
| Integrated Diagnosis & Pathophysiological Chain (PA22.1–22.5) | 6 pts | Synthesises LFT, urinalysis, clinical, and FNAC evidence explicitly into a diagnosis of pancreatic ductal adenocarcinoma with CBD obstruction; mechanistic chain has six or more logically ordered steps covering ductal obstruction, bile back-pressure, failure of intestinal bilirubin delivery, renal excretion of conjugated bilirubin, absence of urobilinogen/stercobilin, and bile-salt mediated pruritus; no logical gaps. |
PEER REVIEW
You will be assigned one anonymous peer submission to review. Use the rubric provided to score each of the five criteria independently. For each criterion:
1. State the score you are awarding (0–full marks).
2. Write 2–3 sentences justifying your score with reference to specific statements in the peer's work.
3. Identify one strength and one specific suggestion for improvement.
Your review must be constructive, evidence-based, and respectful. Reviews that simply state 'good work' or award full marks without justification will not receive credit. Minimum review length: 250 words.